| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 01/03/2021 | 22:15 | GlobeNewswire Inc. | OraSure Technologies, Inc. Announces 2020 Full-Year and Fourth Quarter Financial Results and Provides COVID-19 Update | NASDAQ:OSUR | OraSure Technologies Inc |
| 24/02/2021 | 22:01 | GlobeNewswire Inc. | OraSure Technologies to Present at the Raymond James 42nd Annual Institutional Investors Conference | NASDAQ:OSUR | OraSure Technologies Inc |
| 18/02/2021 | 12:00 | GlobeNewswire Inc. | 2020 Fourth Quarter Earnings Conference Call Monday, March 1, 2021, 5:00 p.m. ET | NASDAQ:OSUR | OraSure Technologies Inc |
| 16/02/2021 | 14:28 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:OSUR | OraSure Technologies Inc |
| 12/02/2021 | 21:21 | Edgar (US Regulatory) | Schedule 13g | NASDAQ:OSUR | OraSure Technologies Inc |
| 11/02/2021 | 12:06 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:OSUR | OraSure Technologies Inc |
| 02/02/2021 | 23:13 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OSUR | OraSure Technologies Inc |
| 29/01/2021 | 12:00 | GlobeNewswire Inc. | OraSure Subsidiary DNA Genotek’s OMNIgene®·ORAL Included in EUA Granted to Ambry Genetics for Use in COVID-19 RT-PCR Sali... | NASDAQ:OSUR | OraSure Technologies Inc |
| 28/01/2021 | 12:00 | GlobeNewswire Inc. | OraSure Subsidiary DNA Genotek’s OMNIgene®·ORAL Saliva Collection Device Receives Health Canada Authorization for use in ... | NASDAQ:OSUR | OraSure Technologies Inc |
| 26/01/2021 | 13:57 | GlobeNewswire Inc. | OraSure’s OMNIgene®·ORAL Saliva Collection Kit Selected by Chronomics for Use in UK Government “Test to Release for Int... | NASDAQ:OSUR | OraSure Technologies Inc |
| 25/01/2021 | 12:00 | GlobeNewswire Inc. | Leading Microbiome Researcher Dr. Eric Pamer Joins Diversigen’s Scientific Advisory Board | NASDAQ:OSUR | OraSure Technologies Inc |
| 21/01/2021 | 12:00 | GlobeNewswire Inc. | OraSure’s Oragene®•Dx Saliva Collection Kit Included in Industry’s First FDA Authorization for a Whole Exome Sequencin... | NASDAQ:OSUR | OraSure Technologies Inc |
| 08/01/2021 | 12:00 | GlobeNewswire Inc. | OraSure Technologies Announces 2021 Annual Meeting Date | NASDAQ:OSUR | OraSure Technologies Inc |
| 05/01/2021 | 12:00 | GlobeNewswire Inc. | OraSure Technologies to Present at the 39th Annual J.P. Morgan Healthcare Conference | NASDAQ:OSUR | OraSure Technologies Inc |
| 23/12/2020 | 12:00 | GlobeNewswire Inc. | OraSure’s OMNIgene®·ORAL Device Included in EUA Amendment Granted to 3B BlackBio Biotech India for SARS-CoV-2 Test | NASDAQ:OSUR | OraSure Technologies Inc |
| 21/12/2020 | 22:01 | GlobeNewswire Inc. | OraSure Technologies Provides Update on Its Emergency Use Authorization Application for Its Lab-based Oral Fluid SARS-CoV-2 ... | NASDAQ:OSUR | OraSure Technologies Inc |
| 30/11/2020 | 13:00 | GlobeNewswire Inc. | OraSure Technologies to Commemorate World AIDS Day by Ringing NASDAQ Closing Bell | NASDAQ:OSUR | OraSure Technologies Inc |
| 30/11/2020 | 13:00 | GlobeNewswire Inc. | OraSure Technologies to Present at the 2020 Evercore ISI HealthCONx Conference | NASDAQ:OSUR | OraSure Technologies Inc |
| 12/11/2020 | 13:00 | GlobeNewswire Inc. | OraSure Technologies to Present at the Stephens Annual Investment Conference 2020 | NASDAQ:OSUR | OraSure Technologies Inc |
| 09/11/2020 | 14:02 | PR Newswire (US) | Clinical Reference Laboratory to Market Most Cost-Effective, Gold-Standard Self-Collected COVID-19 Saliva Test Directly to Co... | NASDAQ:OSUR | OraSure Technologies Inc |
| 05/11/2020 | 22:58 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OSUR | OraSure Technologies Inc |
| 05/11/2020 | 22:21 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:OSUR | OraSure Technologies Inc |
| 04/11/2020 | 22:01 | GlobeNewswire Inc. | OraSure Technologies, Inc. Announces Third Quarter 2020 Financial Results and Provides Update on COVID-19 Developments | NASDAQ:OSUR | OraSure Technologies Inc |
| 03/11/2020 | 13:00 | GlobeNewswire Inc. | OraSure’s DNA Genotek Subsidiary Receives FDA Emergency Use Authorization for its ORAcollect®·RNA Saliva Collection Devic... | NASDAQ:OSUR | OraSure Technologies Inc |
| 21/10/2020 | 12:00 | GlobeNewswire Inc. | OraSure Technologies to Hold 2020 Third Quarter Earnings Conference Call Wednesday, November 4, 2020, 5:00 p.m. ET | NASDAQ:OSUR | OraSure Technologies Inc |
| 19/10/2020 | 12:00 | GlobeNewswire Inc. | OraSure’s OMNIgene®·ORAL Collection Device Receives FDA Emergency Use Authorization for SARS CoV-2 | NASDAQ:OSUR | OraSure Technologies Inc |
| 24/09/2020 | 12:00 | GlobeNewswire Inc. | OraSure’s ORAcollect®·RNA Device Included in EUA Granted to Quadrant Biosciences Inc. for COVID-19 Test | NASDAQ:OSUR | OraSure Technologies Inc |
| 15/09/2020 | 18:00 | GlobeNewswire Inc. | Former CEO of H2O+ Beauty, Former Chief Chemist of MAC Cosmetics Launch Innovative Skincare Brand Using First-Ever Scientific... | NASDAQ:OSUR | OraSure Technologies Inc |
| 09/09/2020 | 19:02 | Dow Jones News | Correction to Rapid Covid-19 Tests Article (Sept. 8) | NASDAQ:OSUR | OraSure Technologies Inc |
| 03/09/2020 | 22:30 | GlobeNewswire Inc. | OraSure’s ORAcollect®·RNA Device Included in EUA Granted to MiraDx Inc. for SARS-CoV-2 Test | NASDAQ:OSUR | OraSure Technologies Inc |